Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Central Oregon Stock Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Sabre Corporation - Common Stock
(NQ:
SABR
)
0.9776
-0.0924 (-8.64%)
Streaming Delayed Price
Updated: 4:00 PM EST, Feb 20, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
22,268,861
Open
1.090
Bid (Size)
0.9500 (500)
Ask (Size)
0.9750 (100)
Prev. Close
1.070
Today's Range
0.8967 - 1.090
52wk Range
0.8967 - 4.630
Shares Outstanding
322,657,316
Dividend Yield
57.28%
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Performance
YTD
-26.5%
-26.5%
1 Month
-28.1%
-28.1%
3 Month
-37.7%
-37.7%
6 Month
-43.5%
-43.5%
1 Year
-78.4%
-78.4%
Frequently Asked Questions
Is Sabre Corporation - Common Stock publicly traded?
Yes, Sabre Corporation - Common Stock is publicly traded.
What exchange does Sabre Corporation - Common Stock trade on?
Sabre Corporation - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Sabre Corporation - Common Stock?
The ticker symbol for Sabre Corporation - Common Stock is SABR on the Nasdaq Stock Market
What is the current price of Sabre Corporation - Common Stock?
The current price of Sabre Corporation - Common Stock is 0.9776
When was Sabre Corporation - Common Stock last traded?
The last trade of Sabre Corporation - Common Stock was at 02/20/26 04:00 PM ET
What is the market capitalization of Sabre Corporation - Common Stock?
The market capitalization of Sabre Corporation - Common Stock is 315.43M
How many shares of Sabre Corporation - Common Stock are outstanding?
Sabre Corporation - Common Stock has 315M shares outstanding.
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.